By creating extended release drugs of orals we can improve the bioavailability of your API. SeraNovo performs oral drug delivery formulations or oral dosage formulations in a stage wise approach.
A feasibility study can be completed in a few months to support oral formulations and show the compatibility of your API and our technology. The results of the study indicate the significant solubility enhancement facilitated with our formulation platform. Our processes are designed to be flexible and fit our client’s timelines.
- High Speed – Feasibility determined in a few months
- Tailored Approach – All parts of formulation designed specifically for each API
- Rapid Transition – Quick transfer to the next phase of formulation development
- DES design
- Prototype dissolution – indicating current and potential bioavailability enhancement
- Solubility optimisation
- Stability – Physical and Chemical